Target intelligence / Profile preview

SLX1B-SULT1A4 readthrough (SLX1B-SULT1A4)

Target
SLX1B-SULT1A4
Molecular classification
Other (read-through transcript), Nonsense-mediated decay candidate
01

Overview

SLX1B-SULT1A4 readthrough is a naturally occurring chimeric transcript resulting from transcriptional read-through between the adjacent SLX1B and SULT1A4 genes on chromosome 16. It is recognized as a candidate for nonsense-mediated mRNA decay and is unlikely to result in production of a protein product or to possess a functional role. The constituent genes, SLX1B and SULT1A4, respectively encode an endonuclease subunit and a phenol-preferring sulfotransferase enzyme, but the read-through transcript itself is not considered a therapeutic target[1][2][4][8].

Other names
SLX1B-SULT1A4SLX1B-SULT1A4 readthroughSLX1 structure-specific endonuclease subunit homolog B–sulfotransferase family cytosolic 1A phenol-preferring member 4 readthrough
02

Mechanism of action

None

03

Biological functions

Other (likely no biological function, as it is a candidate for NMD and does not produce a protein product)
04

Disease associations

None known (no established role in disease)[1][2][4]
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on SLX1B-SULT1A4 readthrough (SLX1B-SULT1A4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SLX1B-SULT1A4 readthrough (SLX1B-SULT1A4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call